Summary
The Second Circuit held that federally funded health centers plausibly alleged that several drug manufacturers engaged in a horizontal price-fixing conspiracy concerning Section 340B discounts for drugs dispensed through contract pharmacies. The court concluded that Astra and Illinois Brick did not bar the plaintiffs’ Sherman Act claims or their limited lost-profit and injunctive-relief requests. It vacated the district court’s dismissal and denial of leave to amend and remanded for the plaintiffs to file their proposed second amended complaint.
Topics
Practice areas
Questions Presented
- Whether the proposed second amended complaint plausibly pleaded a horizontal price-fixing conspiracy under Section 1 of the Sherman Act.
- Whether Astra USA, Inc. v. Santa Clara County barred Plaintiffs' Sherman Act claims because the claims concerned the Section 340B Drug Discount Program.
- Whether Illinois Brick Co. v. Illinois barred Plaintiffs' federal antitrust claims for damages and injunctive relief.
- Whether the district court erred in denying leave to amend as futile.
- Whether the district court was required to reconsider the proposed state-law antitrust and unjust-enrichment claims in light of the adequately pleaded federal conspiracy claim.
Holdings
- Astra did not bar Plaintiffs from bringing Sherman Act claims because Plaintiffs sought relief for an alleged antitrust conspiracy, not enforcement of Section 340B ceiling-price obligations or Pharmaceutical Pricing Agreements.
- Illinois Brick did not bar Plaintiffs from seeking damages for lost access and lost profits rather than overcharge damages.
- Illinois Brick did not bar Plaintiffs' request for injunctive relief under Section 16 of the Clayton Act.
- Antitrust plaintiffs need not plead exactly identical conduct occurring within a tightly synchronized period; conduct may be parallel when it is generally similar in substance, timing, or anticompetitive effect and supports an inference of concerted action.
- The proposed second amended complaint adequately alleged plus factors supporting a plausible inference of conspiracy, including a common motive, conduct contrary to each defendant's individual economic self-interest, and a high level of interfirm communications.
- The district court erred in denying leave to amend as futile because the proposed second amended complaint plausibly stated a Section 1 claim.
Key quotations
“Rather, plaintiffs must state facts consistent with defendants’ having engaged in conduct that contributes to an inference of concerted action.” (24)
“This Court concludes that the proposed second amended complaint pleads sufficient facts to support a plausible inference of a horizontal price-fixing conspiracy through circumstantial allegations, where both (1) the conduct that Plaintiffs allege was sufficiently parallel, as the Defendants’ announced policies were similar enough in substance, timing, and effect; and (2) Plaintiffs alleged sufficient circumstantial plus factors, including a common motive to conspire, parallel conduct contrary to the Defendants’ individual economic self-interest, and a high level of interfirm communications.” (34)
Factual background
Plaintiffs are federally funded safety-net health centers serving low-income patients and participating in the Section 340B Drug Discount Program. Defendants are competing manufacturers of diabetes drugs who allegedly jointly lobbied against the program and then, beginning in 2020, adopted policies restricting or eliminating 340B discounts for drugs dispensed through contract pharmacies. Plaintiffs alleged that the manufacturers' actions were similar in substance, timing, and effect, increased profits, reduced competition, and were supported by common lobbying activity and interfirm communications.
Procedural history
Plaintiffs alleged that drug manufacturers conspired to restrict Section 340B discounts for drugs dispensed through contract pharmacies, in violation of federal and state antitrust law and state common law. The United States District Court for the Western District of New York dismissed the first amended complaint and denied leave to file the proposed second amended complaint, concluding that Plaintiffs had not adequately pleaded parallel conduct or facts supporting an inference of conspiracy. The Second Circuit vacated and remanded, directing the district court to grant leave to file the second amended complaint and to reconsider the state-law claims.
Remand instructions
The district court must grant Plaintiffs leave to file their proposed second amended complaint and reexamine the state-law antitrust and unjust-enrichment claims consistently with the Second Circuit's conclusion that Plaintiffs plausibly alleged a horizontal price-fixing conspiracy.